COVID-19 treatment – St. Peter's Health Partners News

SPHP’s Monoclonal Antibody Program Recognized by Duke University for Best Practices

February 18, 2021 Courtney Weisberg

The Duke Margolis Center for Health Policy has highlighted St. Peter’s Health Partners in its new report “Promising Practices for Promoting Utilization of COVID-19 Monoclonal Antibody Treatments.”

[…]

HANYS: Member Spotlight – St. Peter’s Health Partners Delivers Monoclonal Antibody Therapy to COVID-19 Patients

February 18, 2021 Courtney Weisberg

HANYS recently highlighted St. Peter’s Health Partners in its Member Spotlight for its COVID-19 monoclonal antibody infusion clinic, which has treated more than 550 patients in the Capital Region.

[…]

WTEN: New COVID Antibody Treatment Found Highly Effective in Preventing Hospitalizations

February 16, 2021 Courtney Weisberg

Melissa Fiorini, M.D., clinical director of St. Peter’s Health Partners’ monoclonal antibody infusion clinic, was interviewed by WTEN/News10 about the COVID-19 treatment, including a new antibody recently approved by the FDA.

[…]

WTEN: St. Peter’s Health First in Capital Region to Offer Monoclonal Antibody Therapy for COVID Patients

February 4, 2021 Courtney Weisberg

WTEN/News10 aired a story on the expansion of St. Peter’s Health Partners’ (SPHP) monoclonal antibody therapy program.

[…]

WNYT: Albany Hospital Devoting Entire Unit to Outpatient COVID Treatment

February 4, 2021 Courtney Weisberg

Melissa Fiorini, M.D., emergency medicine and critical care physician at St. Peter’s Health Partners (SPHP), was interviewed by WNYT about SPHP’s monoclonal antibody infusion clinic. Dr. Fiorini oversees the clinic, which is located on the Albany Memorial Campus.

[…]